Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone.
New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...
Good Housekeeping on MSN
Is It Safe to Microdose GLP-1s? Here's What Doctors Want You to Know
Bravo TV host Andy Cohen told the TODAY show that microdosing a GLP-1 drug helped him lose “a good chunk of weight.” The ...
Some research suggests supplements such as berberine, curcumin, resveratrol, fish oil, and probiotics may boost your body's ...
By 2030, households with GLP-1 users are projected to represent 35% of all food and beverage units sold, the consumer ...
GLP-1 RAs are associated with a 62% reduction in 5-year mortality in colon cancer patients, especially those with high obesity. The study's findings remained significant after adjusting for ...
Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...
Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...
GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...
Serena Williams has endorsed GLP-1 medications, raising questions regarding their stigma and performance-enhancing potential for athletes.
NBC News' Anne Thompson joins "Here's the Scoop" co-host Yasmin Vossoughian to talk about why some people are microdosing GLP ...
U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback